Dashboard
Manage Tickers

AGRXAGILE THERAPEUTICS INC

Nasdaq agiletherapeutics.com


$ 0.00 (-0.59 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 0.37775
-- x --
-- x --
-- - --
$ 0.20 - $ 0.49
30,222
na
1.78M
$ -1.34
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-23-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-30-2022 12-31-2021 10-K
11 11-02-2021 09-30-2021 10-Q
12 07-26-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-11-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 02-20-2020 12-31-2019 10-K
19 10-28-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-03-2019 03-31-2019 10-Q
22 03-12-2019 12-31-2018 10-K
23 11-02-2018 09-30-2018 10-Q
24 08-03-2018 06-30-2018 10-Q
25 05-07-2018 03-31-2018 10-Q
26 03-12-2018 12-31-2017 10-K
27 11-06-2017 09-30-2017 10-Q
28 07-28-2017 06-30-2017 10-Q
29 05-08-2017 03-31-2017 10-Q
30 03-15-2017 12-31-2016 10-K
31 11-07-2016 09-30-2016 10-Q
32 08-08-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 03-09-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-13-2015 06-30-2015 10-Q
37 05-12-2015 03-31-2015 10-Q
38 03-26-2015 12-31-2014 10-K
39 11-13-2014 09-30-2014 10-Q
40 08-14-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

agile-therapeutics-q1-2024-adj-eps-063-misses-051-estimate-sales-572m-beat-375m-estimate
Agile Therapeutics Q1 2024 Adj EPS $(0.63)...
05/15/2024 20:43:30

Agile Therapeutics (NASDAQ:AGRX) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of ...

agile-therapeutics-q4-adj-146-misses-092-estimate-sales-362m-miss-407m-estimate
Agile Therapeutics Q4 Adj $(1.46) Misses $...
03/28/2024 12:17:13

Agile Therapeutics (NASDAQ:AGRX) reported quarterly losses of $(1.46) per share which missed the analyst consensus estimate of ...

agile-therapeutics-q4-earnings-insights
Agile Therapeutics: Q4 Earnings Insights
03/28/2024 12:15:07

agile-therapeuticss-earnings-a-preview
Agile Therapeutics's Earnings: A Preview
03/27/2024 14:00:56

why-agile-therapeutics-agrx-stock-is-down-60
Why Agile Therapeutics (AGRX) Stock Is Dow...
03/26/2024 16:18:07

Agile Therapeutics shares are trading lower by 61% during Tuesday's session. The company announced the suspension of its tr...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
03/25/2024 21:32:19

agile-therapeutics-reveals-final-delisting-notice-from-nasdaq
Agile Therapeutics Reveals Final Delisting...
03/25/2024 20:31:22

Suspension of trading in the Company's common stock on the Nasdaq exchange will be effective at the open of trading on Marc...

earnings-scheduled-for-march-22-2024
Earnings Scheduled For March 22, 2024
03/22/2024 09:40:22

Companies Reporting Before The Bell • Agile Therapeutics (NASDAQ:AGRX) is likely to report quarterly loss at $0.54 per share o...

agile-therapeuticss-earnings-a-preview
Agile Therapeutics's Earnings: A Preview
03/21/2024 14:00:16

maxim-group-downgrades-agile-therapeutics-to-hold
Maxim Group Downgrades Agile Therapeutics ...
03/18/2024 12:56:06

Maxim Group analyst Naz Rahman downgrades Agile Therapeutics (NASDAQ:AGRX) from Buy to Hold.

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
03/13/2024 13:06:03

agile-therapeutics-announced-that-it-has-paid-off-the-remainder-of-its-debt-facility-with-perceptive-advisors-the-company-remains-focused-on-growing-twirla-and-advancing-the-companys-business-plan
Agile Therapeutics Announced That It Has P...
03/13/2024 11:42:11

Core News & Articles
'France becomes first country to explicitl...
03/04/2024 17:53:02

https://www.washingtonpost.com/world/2024/03/04/france-abortion-constitution/

why-etsy-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Etsy Shares Are Trading Lower By Aroun...
02/22/2024 18:37:58

Shares of Etsy, Inc.

whats-going-on-with-women-health-focused-agile-therapeutics-stock-today
What's Going On With Women Health Focused ...
02/22/2024 18:26:09

Agile Therapeutics stock rises on premarket trading, exercising warrants for $4.8M gross proceeds with reduced exercise price o...

agile-therapeutics-announces-exercise-of-warrants-for-48m-gross-proceeds
Agile Therapeutics Announces Exercise of W...
02/22/2024 14:08:17

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
02/22/2024 13:05:56

why-nvidia-shares-are-trading-higher-by-around-14-here-are-20-stocks-moving-premarket
Why NVIDIA Shares Are Trading Higher By Ar...
02/22/2024 12:55:25

Shares of NVIDIA Corporation (NASDAQ: NVDA) rose sharply in today’s pre-market trading after the company reported better-than-...

5-value-stocks-in-the-healthcare-sector
5 Value Stocks In The Healthcare Sector
02/19/2024 14:42:59

agile-therapeutics-announces-extension-granted-by-nasdaq-hearings-panel-to-regain-compliance-until-march-25-2024-sees-fy23-revenue-20m-21m
Agile Therapeutics Announces Extension Gra...
02/15/2024 21:55:52

Company Granted Extension by Nasdaq Hearings Panel to Regain Compliance with the Stockholders' Equity Continued Listing Req...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION